Holen Sie sich die Stockscreener-App
69.10
2.92%
1.96
Handel nachbörslich:
69.10
Utah Medical Products Inc Aktie (UTMD) Neueste Nachrichten
Utah Medical Products Inc (UTMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Utah Medical Products Inc (UTMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Utah Medical Products, Inc. Revenue Breakdown – NASDAQ:UTMD - TradingView
Utah Medical Products Releases Q2 2026 Financial Results - AlphaStreet
Utah Medical Products Inc (UTMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Is Utah Medical Products Inc (UTMD) Facing Valuation Challenges - GuruFocus
UTMD: Revenue and profit fell on lost customers, but margins and cash position remain strong - TradingView
Utah Medical reports Q2 sales down 14.3% to $8.53M, net income $2.69M; 1H sales down 12.3% - TradingView
UTMD Reports Q2 Revenue Decline to $8.5M - GuruFocus
Utah Medical: Q2 Earnings Snapshot - AOL.com
BRIEF-Utah Medical Products Q2 Sales USD 8.529 Million - TradingView
Utah Medical expects zero 2026 sales from two former customers; 10%-13% drop - Stock Titan
UTMD|Utah Medical Products Inc|Price:67.140|Chg%:+2.960 - TradingKey
(UTMD) and the Role of Price-Sensitive Allocations - Stock Traders Daily
World Cautery MachineMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Utah Medical Products (UTMD) Shows Modest Uptick as Consolidation ContinuesZero Gamma Level - dars.gov.et
Reusable Grounding Cable Market Forecast Points Higher Toward 2035, Driven by Rising Surgical Volumes and Safety Mandates - IndexBox
Utah Medical Products Inc. (UTMD) Climbs 2.5% as Stock Approaches Key Resistance LevelDiamond Pattern - dars.gov.et
Thoracic Drainage Devices Market Intelligence Report Covers Trends, Segments And Regional Growth - openPR.com
Utah Medical Products (UTMD) slides 2.5%, testing near-term support after heavy-volume sessionFlat Correction - dars.gov.et
Utah Health System Beats 401(k) Suit Over Stable Value Fund - Law360
H5N1 Bird Flu Returned to Utah Commercial Egg Operations Last Week, Wiping Out 1.2 Million Hens - Medical Daily
Pneumothorax Treatment Devices Market Analysis Highlights Growth To $6.43 Billion By 2030 At 10% CAGR - openPR.com
LUCD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Utah Medical Products Inc. (UTMD) Edges Higher; Consolidation Near Key LevelsSeasonality Effect - dars.gov.et
Peripherally Inserted Central Catheter (PICC) Market - openPR.com
Peritoneal Dialysis Market worth $14.16 billion by 2031 | MarketsandMarkets™ - PR Newswire UK
Fetal And Neonatal Monitoring Devices Market Outlook Highlights Strategic Opportunities Across The Industry - openPR.com
Electrosurgical Smoke Evacuation Systems Market Report Examines Leading Companies And Growth Opportunities - openPR.com
Utah Medical's Q1 earnings fall y/y due to elevated litigation costs - MSN
Enterprise value to EBITDA forward of Utah Medical Products, Inc. – NASDAQ:UTMD - TradingView
Enterprise value to EBIT forward of Utah Medical Products, Inc. – NASDAQ:UTMD - TradingView
Enterprise value to revenue forward of Utah Medical Products, Inc. – NASDAQ:UTMD - TradingView
Price to earnings forward of Utah Medical Products, Inc. – NASDAQ:UTMD - TradingView
Biomedical Pressure Sensor Market Outlook Highlights Strategic Opportunities Across The Industry - openPR.com
Electrosurgical Devices and Equipment Global Market Forecast Points Higher Toward 2035, Driven by Minimally Invasive Surgery Expansion - IndexBox
Price to book forward of Utah Medical Products, Inc. – NASDAQ:UTMD - TradingView
Price to sales forward of Utah Medical Products, Inc. – NASDAQ:UTMD - TradingView
Form 4 Utah Medical Products Inc For: 1 July By Investing.com - Investing.com Nigeria
UTAH MEDICAL PRODUCTS (UTMD) director reports 150-share bona fide stock gift - Stock Titan
Responsive Playbooks and the UTMD Inflection - Stock Traders Daily
World Postpartum Hemorrhage Treatment DeviceMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
UTMD Q1 2024 Earnings: Solid EPS Delivers Double‑Digit Share Price GainRevenue Estimate Trend - dars.gov.et
UTMD Q1 2024 Earnings: Steady EPS Performance Amid Quiet Market ResponseProfit Cycle Analysis - dars.gov.et
Utah Medical Products Inc (UTMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Monopolar Grounding Pad Electrodes Market Growth Outlook to 2035: Surgical Demand and Product Innovation AccelerateNews and Statistics - IndexBox
Utah Medical Products (UTMD) Gains Nearly 2% as Stock Approaches Key Resistance LevelSector ETF Flow - dars.gov.et
World Peripheral Arterial Line TransducersMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
World Cautery Pencils and HandlesMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Utah Medical Products Inc (UTMD) Institutional Confidence - TradingKey
Utah Medical Products (UTMD) Shows Resilience: Gains 2% as It Eyes Key ResistancePrice Target - DonanımHaber
Utah Medical Products Inc (UTMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Utah Medical Products Inc (UTMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Utah Medical Products StockThursday chart snapshot and volatility check - Ad-hoc-news.de
Utah Medical Products Inc (UTMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Utah Medical Products Inc (UTMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Utah Medical Products, Inc.: - marketscreener.com
UTMD Q1 2024 Earnings: EPS of $1.09 Drives Positive Stock Reaction Amid Limited Financial Disclosure - newsline.com
Utah Medical Products Inc. (UTMD) Q1 2024 Earnings: Positive EPS and Stock Uptick Amid Limited DisclosuresMid-Term Outlook - dars.gov.et
UTMD Q1 2024 Earnings: EPS of $1.09 Highlights Stability Amid Stock PullbackEarnings Growth Analysis - newsline.com
UTMD Q1 2024 Earnings: EPS of $1.09 as Stock Declines 2.3% Amid Quiet ReleaseLow Estimate Range - newsline.com
0.62%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):